세계의 남성 불임증 시장 보고서(2025년)
Male Fertility Global Market Report 2025
상품코드 : 1825443
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

남성 불임증 시장 규모는 향후 수년간 안정된 성장이 전망됩니다. 2029년에는 CAGR 4.2%로 49억 3,000만 달러로 성장합니다. 예측 기간의 성장은 인구 고령화, 남성 불임 질환의 유병률 증가, 보조생식술에 대한 수요 증가, 불임 치료 접근성 확대, 남성 불임 솔루션의 연구개발 증가에 기인합니다. 예측 기간의 주요 동향으로는 남성 불임 치료의 맞춤형 의료, 진단 및 치료에 인공지능과 빅데이터 분석의 통합, 남성 불임을 개선하기 위한 자연적이고 총체적인 접근 방식으로의 전환, 불임 상담을 위한 원격의료 및 원격 모니터링, 남성 불임 치료에서 정신건강 및 스트레스 관리의 중요성 등을 들 수 있습니다.

향후 5년간 성장률 4.2%라는 예측은 지난번 예측보다 0.1% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 인상은 스웨덴과 프랑스에서 조달하는 정자 분석 장비와 호르몬 치료 비용을 높이고, 불임 치료 비용을 악화시키고, 가족계획 서비스를 지연시킴으로써 미국 클리닉에 부담을 줄 가능성이 높습니다. 또한 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

불임 조사에 대한 자금 지원 증가는 향후 불임 조사 시장의 성장을 가속할 것으로 예측됩니다. 불임 치료 연구는 임신, 임신, 불임 치료 결과의 최적화를 포함하되 이에 국한되지 않는 생식 건강에 영향을 미치는 요인에 대한 과학적 조사 및 연구를 포함합니다. 불임 연구 자금 지원은 생식 건강을 종합적으로 이해하고, 전반적인 불임 치료 결과를 개선하고, 남성 요인이 임신과 생식 성공에 미치는 중요한 역할을 해결하기 위해 남성 불임에 대한 조사를 우선시합니다. 예를 들어 2023년 10월, 미국에 본부를 둔 보건 부문인 유니스 케네디 슈라이버 국립 아동 건강 및 인간 개발 연구소에 따르면 불임 치료를 피하는 치료법 연구에 226만 달러를 지원했습니다. 또한 2022년 9월에는 호주에 본사를 둔 의료 연구 기관인 MRFF(Medical Research Future Fund)가 자궁내막증 환자 지원, 불임 치료 옵션 탐색, 임상 등록 개선을 위해 총 330만 달러의 보조금을 수여했습니다. 따라서 불임 연구에 대한 자금 지원 증가가 남성 불임 시장의 성장을 주도하고 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Male fertility is commonly defined as the capability of a man to impregnate his female partner. It involves a complex process reliant on the production of healthy sperm, the proper functioning of male reproductive organs, and the ability to achieve an erection and ejaculate, facilitating the sperm's journey to reach the egg.

In the realm of male fertility testing, various test types are employed, including sperm agglutination, DNA fragmentation analysis, oxidative stress analysis, computer-assisted semen analysis, sperm penetration assay, and other diagnostic methods. Sperm agglutination refers to the clustering of sperm cells, often caused by the presence of antibodies on the sperm cell surface or in the surrounding seminal fluid. Treatment options for male fertility issues typically involve assisted reproductive technology, varicocele surgery, and medication. Medications may include antioxidants, vitamins, minerals, amino acids, and enzymes. These treatments are administered in hospitals, clinics, fertility centers, research institutes, and other end-user settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The male fertility market research report is one of a series of new reports from The Business Research Company that provides male fertility market statistics, including male fertility industry global market size, regional shares, competitors with male fertility market share, detailed male fertility market segments, market trends, and opportunities, and any further data you may need to thrive in the male fertility industry. This male fertility market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The male fertility market size has grown strongly in recent years. It will grow from $3.96 billion in 2024 to $4.18 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to changing lifestyles and habits, environmental factors, advancements in medical technology, increasing awareness and acceptance of male fertility issues, socioeconomic factors.

The male fertility market size is expected to see steady growth in the next few years. It will grow to $4.93 billion in 2029 at a compound annual growth rate (CAGR) of 4.2%. The growth in the forecast period can be attributed to aging population, rising prevalence of male fertility disorders, growing demand for assisted reproductive technologies, expanding access to fertility treatments, increasing research and development in male fertility solutions. Major trends in the forecast period include personalized medicine in male fertility treatments, integration of artificial intelligence and big data analytics in diagnosis and treatment, shift towards natural and holistic approaches to improve male fertility, telemedicine and remote monitoring for fertility consultations, emphasis on mental health and stress management in male fertility care.

The forecast of 4.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. clinics by driving up the cost of sperm analysis equipment and hormonal therapies sourced from Sweden and France, exacerbating fertility treatment costs and delaying family planning services. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing funding for fertility research is expected to propel the growth of the male fertility market going forward. Fertility research encompasses the scientific investigation and study of factors influencing reproductive health, including but not limited to conception, pregnancy, and the optimization of fertility outcomes. Funding for fertility research prioritizes investigations into male fertility to comprehensively understand reproductive health, improve overall fertility outcomes, and address the significant role that male factors play in conception and reproductive success. For instance, in October 2023, according to the Eunice Kennedy Shriver National Institute of Child Health and Human Development, a US-based health department, granted $2.26 million to study fertility-sparing treatments. Further, in September 2022, the Medical Research Future Fund (MRFF), an Australia-based medical research organization, awarded a total of $3.3 million in grants to support endometriosis sufferers, search for fertility options, and improve clinical registries. Therefore, the increasing funding for fertility research is driving the growth of the male fertility market.

Major companies operating in the male fertility market are focusing on innovation in services such as testing services to help people access information about their fertility, allowing them to take greater control of their reproductive health. A testing service is a service that provides testing or analysis of a particular substance or condition. For instance, in November 2022, Superdrug Stores plc, a UK-based retail company, launched the UK's first male fertility service on the high street. The testing service consists of a clinical-grade sperm test, comparable to a World Health Organization or NHS test, and is accepted by most fertility treatments. The services also offer clinical-grade semen analysis that uses 'state-of-the- art' AI microscopes. Results analyze 22 different parameters, including morphology-the size and shape of sperm. The discreet, at-home test kit can be picked up in store and taken home. The sample will then be picked up by a courier, and results will be available 48 hours after the lab receives them. A full diagnostic report will be provided, which can be used for onward referrals or reviews with a fertility specialist.

In March 2022, Ro, a US-based digital health company, acquired Dadi for an undisclosed amount. With this acquisition, Ro aims to expand its fertility offerings and make these services more accessible, convenient, and affordable. Dadi is a US-based fertility company specializing in sperm testing, analysis, and storage.

Major companies operating in the male fertility market report are Bayer Healthcare Inc., Sanofi S.A., MERCK KGaA, Essity AB, Laboratory Corporation Of America Holdings, Endo International plc., Cook Medical, Zydus Lifesciences Ltd., Intas Pharmaceuticals Ltd., ASKA Pharmaceutical Co. Ltd., EMD Serono Inc., Dendreon Pharmaceuticals LLC, Vitrolife, CinnaGen Co., Aytu BioScience Inc., Kindbody, Cryos International, AdvaCare Pharma USA, Ferring Pharmaceuticals, Apricus Biosciences, Reprotech Ltd., Vios Fertility Institute, Andrology Solutions, DxNow, Epicypher, INVO Bioscience

North America was the largest region in the male fertility market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the male fertility market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the male fertility market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The male fertility market includes revenues earned by entities by diagnostic testing services, fertility consultations and counselling, fertility treatments and therapies or sperm banking and storage services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Male Fertility Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on male fertility market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for male fertility ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The male fertility market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Male Fertility Market Characteristics

3. Male Fertility Market Trends And Strategies

4. Male Fertility Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Male Fertility Growth Analysis And Strategic Analysis Framework

6. Male Fertility Market Segmentation

7. Male Fertility Market Regional And Country Analysis

8. Asia-Pacific Male Fertility Market

9. China Male Fertility Market

10. India Male Fertility Market

11. Japan Male Fertility Market

12. Australia Male Fertility Market

13. Indonesia Male Fertility Market

14. South Korea Male Fertility Market

15. Western Europe Male Fertility Market

16. UK Male Fertility Market

17. Germany Male Fertility Market

18. France Male Fertility Market

19. Italy Male Fertility Market

20. Spain Male Fertility Market

21. Eastern Europe Male Fertility Market

22. Russia Male Fertility Market

23. North America Male Fertility Market

24. USA Male Fertility Market

25. Canada Male Fertility Market

26. South America Male Fertility Market

27. Brazil Male Fertility Market

28. Middle East Male Fertility Market

29. Africa Male Fertility Market

30. Male Fertility Market Competitive Landscape And Company Profiles

31. Male Fertility Market Other Major And Innovative Companies

32. Global Male Fertility Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Male Fertility Market

34. Recent Developments In The Male Fertility Market

35. Male Fertility Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기